Why the study?
While oral anticoagulation is standard of care for AF, LAAC has emerged as an alternative or complementary approach, warranting a review of recent clinical data, ongoing studies, open questions, and current limitations.
Does left atrial appendage closure reduce the risk of stroke or systemic embolism in patients with atrial fibrillation?
Does left atrial appendage closure reduce the risk of stroke or systemic embolism in patients with atrial fibrillation?
Left atrial appendage closure is an evolving alternative or complementary treatment to oral anticoagulation for stroke prevention in patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Evidence on LAAC for AF stroke prevention remains limited by design and follow-up; leaves open definitive trials versus contemporary anticoagulation.
Atrial fibrillation (AF) is associated with an increased risk of stroke and systemic embolism, and the left atrial appendage (LAA) has been identified as a principal source of thromboembolism in these patients. While oral anticoagulation is the current standard of care, LAA closure (LAAC) emerges as an alternative or complementary treatment approach to reduce the risk of stroke or systemic embolism in patients with AF. Moderate-sized randomized clinical studies have provided data for the efficacy and safety of catheter-based LAAC, largely compared with vitamin K antagonists. LAA device iterations, advances in pre- and peri-procedural imaging, and implantation techniques continue to increase the efficacy and safety of LAAC. More data about efficacy and safety of LAAC have been collected, and several randomized clinical trials are currently underway to compare LAAC with best medical care (including non-vitamin K antagonist oral anticoagulants) in different clinical settings. Surgical LAAC in patients with AF undergoing cardiac surgery reduced the risk of stroke on background of anticoagulation therapy in the LAAOS III study. In this review, we describe the rapidly evolving field of LAAC and discuss recent clinical data, ongoing studies, open questions, and current limitations of LAAC.
No takes yet. Share an insight, caveat, or question.
Landmesser et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: